Expert Council for the Supervision of Immunoprophylaxis

In 2022, adapted vaccines according to current variants of the coronavirus are expected to be approved. Currently, the third dose uses vaccines that we have, but a combination is allowed - in the first and second dose of vector vaccine to be given an mRNA vaccine.